These results indicate that pharmacological activation of EP4 suppresses foam cell formation and M1 polarization, thereby promoting an anti-inflammatory macrophage phenotype, which may potentially ameliorate atherosclerosis. Here, PTGER4 is linked to atherosclerosis.